Treatment of Meningitis Due to Methicillin-Resistant Staphylococcus epidermidis with Linezolid
AUTOR(ES)
Krueger, Wolfgang A.
FONTE
American Society for Microbiology
RESUMO
Methicillin-resistant Staphylococcus epidermidis (MRSE) can cause nosocomial meningitis in the presence of prosthetic devices. Vancomycin is the treatment of choice, but its penetration into the cerebrospinal fluid is poor, especially in cases without severe meningeal inflammation. We successfully used linezolid to treat a case of posttraumatic MRSE meningitis with a low-level inflammatory response. Therapeutic effectiveness was documented microbiologically and by the simultaneous measurement of linezolid levels in serum and cerebrospinal fluid.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=344467Documentos Relacionados
- Detection of methicillin-resistant Staphylococcus epidermidis.
- Efficacy of Linezolid Alone or in Combination with Vancomycin for Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus
- Influence of papain in biofilm formed by methicillin-resistant Staphylococcus epidermidis and methicillin-resistant Staphylococcus haemolyticus isolates
- Infections due to methicillin-resistant strains of Staphylococcus pyogenes
- Reduced Triclosan Susceptibility in Methicillin-Resistant Staphylococcus epidermidis